Multiomic ALS signatures highlight sex differences and molecular subclusters and identify the MAPK pathway as therapeutic target

Archive ouverte

Gomes, Lucas Caldi | Hänzelmann, Sonja | Oller, Sergio | Parvaz, Mojan | Hausmann, Fabian | Khatri, Robin | Ebbing, Melanie | Holzapfel, Constantin | Pasetto, Laura | Columbro, Stefano Fabrizio | Scozzari, Serena | Gebelin, Marie | Knöferle, Johanna | Cordts, Isabell | Demleitner, Antonia | Tzeplaeff, Laura | Deschauer, Marcus | Dufke, Claudia | Sturm, Marc | Zhou, Qihui | Zelina, Pavol | Sudria-Lopez, Emma | Haack, Tobias | Streb, Sebastian | Kuzma-Kozakiewicz, Magdalena | Edbauer, Dieter | Pasterkamp, R. Jeroen | Laczko, Endre | Rehrauer, Hubert | Schlapbach, Ralph | Carapito, Christine | Bonetto, Valentina | Bonn, Stefan | Lingor, Paul

Edité par CCSD -

Abstract Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease and lacks effective disease-modifying treatments. Here, we performed a multiomic analysis of the prefrontal cortex of 51 patients with sporadic ALS and 50 control subjects, as well as four transgenic mouse models of C9orf72-, SOD1-, TDP-43-, and FUS-ALS to characterize early and sex-specific disease mechanisms in ALS. Integrated analyses of transcriptomes, (phospho)proteomes, and miRNAomes revealed more pronounced changes in male patients. We identified transcriptome-based human ALS subclusters driven by the immune response, extracellular matrix, mitochondrial respiration, and RNA metabolism. The molecular signatures of human subclusters were reflected in specific mouse models. Individual and integrative multiomics analyses highlighted the mitogen-activated protein kinase pathway as an early disease-relevant mechanism. Its modulation by trametinib in vitro and in vivo validated that mitogen-activated protein kinase kinase 2 is a promising therapeutic target with beneficial effects in female patients.

Consulter en ligne

Suggestions

Du même auteur

Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic target

Archive ouverte | Caldi Gomes, Lucas | CCSD

International audience. Amyotrophic lateral sclerosis (ALS) is a debilitating motor neuron disease and lacks effective disease-modifying treatments. This study utilizes a comprehensive multiomic approach to investig...

msqrob2PTM: differential abundance and differential usage analysis of MS-based proteomics data at the post-translational modification and peptidoform level

Archive ouverte | Demeulemeester, Nina | CCSD

International audience. In the era of open-modification search engines, more post-translational modifications than ever can be detected by LC-MS/MS-based proteomics. This development can switch proteomics research i...

Bi-allelic HPDL Variants Cause a Neurodegenerative Disease Ranging from Neonatal Encephalopathy to Adolescent-Onset Spastic Paraplegia

Archive ouverte | Husain, Ralf | CCSD

International audience. We report bi-allelic pathogenic HPDL variants as a cause of a progressive, pediatric-onset spastic movement disorder with variable clinical presentation. The single-exon gene HPDL encodes a p...

Chargement des enrichissements...